glp-1 receptor agonist brand names Shortage: Challenges and Solutions in Type 2 Diabetes Care A Tale of Two Incretins

Nat Rev Endocrinol 19 , 201216 (2023)

Millions of people with Medicare and Medicaid could benefit from expanded coverage of GLP-1s for obesity Overall, CMSs efforts to expand Medicare and Medicaid coverage of GLP-1s for people with Medicare and Medicaid could greatly expand access to these drugs, albeit on a temporary basis, depending on the level of participation by drug manufacturers, state Medicaid agencies and Part D plans

Unlike the injection, which can be given at any time, the pill requires a strict fasting window

Adverse events were also reported, including acute pancreatitis, severe hypoglycaemia and gastrointestinal side effects

Why People Are Seeking Ozempic Alternatives While Ozempic has delivered positive outcomes for many, there are a few common reasons people explore alternatives: High cost or insurance restrictions Limited availability due to high demand Unwanted side effects like nausea, fatigue, or GI discomfort Preference for daily or non-injectable formats Interest in lower-dose or custom-compounded options The good news is that safe, effective alternatives existand with proper medical oversight, you can find one that fits your weight loss goals

Obesity is a chronic condition, just like diabetes